Mobile Stroke Unit (MSU): The Future of Acute Stroke Treatment?

Journal Title: Neuro – Open Journal - Year 2016, Vol 3, Issue 1

Abstract

Time is the key factor in brain survivability in acute stroke treatment.1The therapeutic effects of intravenous recombinant tissue Plasminogen Activator (IV rtPA) are highly dependent on time.1-3 Stroke patients presenting within the first 60 minutes, or the golden hour, are the most likely to benefit from recanalization therapy.1-3 Thus, making rapid clinical and imaging evaluation of stroke patients of upmost importance and very difficult to complete within the golden hour time window. Based on Get with the Guidelines-Stroke Program (April 2003 to October 2009), less than one-third of patients treated with IV rtPA have door-to-needle times of less than 60 minutes.

Authors and Affiliations

Waldo R. Guerrero

Keywords

Related Articles

Blue Cone Signals in the Extra Striate Cortex: Explanation for Blind Sight?

Our perception of vision is largely as a result of the signals conveyed from the eye to the brain via the retino-thalamo-cortical pathway. Visual signals within this pathway originate from three cone photoreceptors (resp...

Neuromodulation in the Treatment of Migraine: Progress in Nerve Stimulation

Migraine is a type of primary headache disorder that can become chronic and disabling. The exact pathomechanism of migraine is not known very well and its treatment is also difficult in some cases. There are several medi...

Chronic Subdural Haematoma: Systematic Review Highlighting Risk Factors for Recurrent Bleeds

Introduction: Chronic subdural haematoma (CSDH) is one of the commonest forms of intracranial haemorrhage. Surgical drainage of CSDH is a routine operation in the modern neurosurgical practice which has shown to be the m...

Intra-Abdominal Ventriculoperitoneal Shunt Abscess from Streptococcus Pyogenes after Pharyngitis with Scarlet Fever: Case Report and Review of the Literature

Objective: Infection is one of the most frequent complications of ventriculoperitoneal shunts. However, Streptococcus pyogenes (Group A Streptococcus, GAS) as a causative agent appears to be extremely rare. We present an...

An Unusual Intracranial Inflammatory Process of Unknown Origin

We present an unusual case of steroid responsive inflammatory condition, involving sellar suprasellar region with further ependymal lesions. This is complicated by previous surgery due to pituitary adenoma, not thought t...

Download PDF file
  • EP ID EP552535
  • DOI 10.17140/NOJ-3-e005
  • Views 114
  • Downloads 0

How To Cite

Waldo R. Guerrero (2016). Mobile Stroke Unit (MSU): The Future of Acute Stroke Treatment?. Neuro – Open Journal, 3(1), 1-4. https://europub.co.uk/articles/-A-552535